Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,585
  • Shares Outstanding, K 81,288
  • Annual Sales, $ 229,500 K
  • Annual Income, $ -217,200 K
  • 60-Month Beta 2.00
  • Price/Sales 0.23
  • Price/Cash Flow N/A
  • Price/Book 0.90
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.03
  • Most Recent Earnings 0.25 on 08/07/19
  • Next Earnings Date 05/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +454,190.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5500 +19.38%
on 03/18/20
1.1600 -43.40%
on 03/09/20
-0.4834 (-42.40%)
since 03/06/20
3-Month
0.5500 +19.38%
on 03/18/20
1.7100 -61.60%
on 02/07/20
-0.4234 (-39.20%)
since 01/06/20
52-Week
0.5500 +19.38%
on 03/18/20
5.6800 -88.44%
on 04/09/19
-4.8334 (-88.04%)
since 04/05/19

Most Recent Stories

More News
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - WLTW, TTPH, ASRT, MEET

Halper Sadeh LLP, a global investor rights law firm, investigates whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures...

WLTW : 172.39 (+9.74%)
TTPH : 1.0411 (+5.16%)
ASRT : 0.6597 (+3.96%)
MEET : 5.98 (+1.01%)
Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products

Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million

ASRT : 0.6597 (+3.96%)
ZCOR : 1.5000 (+7.14%)
PDL BioPharma (PDLI) Misses on Q4 Earnings, To Dissolve by Year-End

PDL BioPharma's (PDLI) earnings lag estimates in the fourth quarter. The company announces plan to complete liquidation by the end of 2020.

PDLI : 2.79 (+4.89%)
ADRO : 2.79 (+9.84%)
EVFM : 5.08 (+3.04%)
ASRT : 0.6597 (+3.96%)
Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024

Assertio Therapeutics, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), today announces that it has commenced cash tender offers (the "Offers") to purchase any and all of the outstanding $42,465,000...

ASRT : 0.6597 (+3.96%)
Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of -200.00% and 17.75%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

ASRT : 0.6597 (+3.96%)
Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2019 Financial Results

-- Reports Neurology Franchise Annual Net Sales of $108.1 Million, Exceeding Upper End of Prior Guidance --

ASRT : 0.6597 (+3.96%)
Assertio Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 9, 2020 / Assertio Therapeutics, Inc. (NASDAQ:ASRT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 9, 2020 at...

ASRT : 0.6597 (+3.96%)
Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020

Assertio Therapeutics, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), today announced that it will release fourth quarter and full year 2019 financial results on Monday, March 9, 2020, after the close...

ASRT : 0.6597 (+3.96%)
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for

Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASRT : 0.6597 (+3.96%)
Assertio (ASRT) to Report Q4 Earnings: What's in Store?

During Q4 earnings call, Assertio (ASRT) is likely to provide an update on its recently implemented cost-saving initiatives and the sales performance of its marketed drugs.

SAGE : 28.13 (+8.40%)
COLL : 16.99 (+5.33%)
VCEL : 9.15 (+7.65%)
ASRT : 0.6597 (+3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ASRT with:

Business Summary

Assertio Therapeutics, Inc. is a pharmaceutical company. It develops and markets a product for the treatment in neurology, orphan and diseases of the central nervous system. Assertio Therapeutics, Inc., formerly known as Depomed Inc., is headquartered in Lake Forest, Illinois.

See More

Key Turning Points

2nd Resistance Point 0.6760
1st Resistance Point 0.6553
Last Price 0.6597
1st Support Level 0.6175
2nd Support Level 0.6004

See More

52-Week High 5.6800
Fibonacci 61.8% 3.7203
Fibonacci 50% 3.1150
Fibonacci 38.2% 2.5097
Last Price 0.6597
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar